Date: 2011-11-30
Type of information: Services contract
Compound: vaccine candidate against bovine (cattle) neosporosis
Company: Vitamfero (France) Oniris (France)
Therapeutic area: Veterinary medicine
Type agreement: collaboration
services
Action mechanism:
Disease: neosporosis
Details: * On November 30, 2011, VitamFero, a biotechnology firm in the Genopole cluster that develops novel vaccines to prevent specific parasitic diseases, and Oniris, an institute of higher education and specialized research, particularly in human and animal health, announced the signing of a services contract to study the efficacy of a new generation vaccine candidate against bovine (cattle) neosporosis.
Financial terms:
Latest news: